Evidence map›Paper›PMID 23393168›Full record

ReviewThe Journal of clinical endocrinology and metabolism2013

Marrow fat and bone--new perspectives.

Pouneh K Fazeli, Mark C Horowitz, Ormond A MacDougald, Erica L Scheller, Matthew S Rodeheffer, Clifford J Rosen, Anne Klibanski

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 242 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
242citing papers in PubMed, 1 pooled it
24.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

242 citing papers in PubMed, 1 synthesis or guideline pooled it, 416 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Impact of pioglitazone on bone mineral density and bone marrow fat content.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Aging-Driven Inter-Organ Crosstalk in Postmenopausal Osteoporosis: From Immunometabolic Drift to Multisystem Frailty.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

182 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Pouneh K FazeliNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Mark C Horowitz
Ormond A MacDougald
Erica L Scheller
Matthew S Rodeheffer
Clifford J Rosen
Anne Klibanski
University of Michigan–Ann Arbor · USYale University · USHarvard University · USMaine Medical Center Research Institute · USMassachusetts General Hospital · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy BalanceR24DK092759 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, MACDOUGALD, ORMOND A · 2011 to 2019
$13.0M
YALE CORE CENTER FOR MUSCULOSKELETAL DISORDERSP30AR046032 · NIAMS · YALE UNIVERSITY · PI INSOGNA, KARL LEONARD · 1999 to 2013
$9.0M
The Role of PTH in the Low Bone Mass of Anorexia NervosaK23DK094820 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FAZELI, POUNEH KHADEJEH · 2012 to 2015
$746k
NIAMS NIH HHS P30 AR046032NIAMS NIH HHS P30AR046032NIDDK NIH HHS K23 DK094820NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R24 DK092759NIDDK NIH HHS R24DK092759
6 · The paper itself

Abstract

contextThere is growing interest in the relationship between bone mineral density, bone strength, and fat depots. Marrow adipose tissue, a well-established component of the marrow environment, is metabolically distinct from peripheral fat depots, but its functional significance is unknown.

objectiveIn this review, we discuss animal and human data linking the marrow adipose tissue depot to parameters of bone density and integrity as well as the potential significance of marrow adipose tissue in metabolic diseases associated with bone loss, including type 1 diabetes mellitus and anorexia nervosa. Potential hormonal determinants of marrow adipose tissue are also discussed.

conclusionsWe conclude that whereas most animal and human data demonstrate an inverse association between marrow adipose tissue and measures of bone density and strength, understanding the functional significance of marrow adipose tissue and its hormonal determinants will be critical to better understanding its role in skeletal integrity and the role of marrow adipose tissue in the pathophysiology of bone loss.

Indexed as

Bone MarrowAdipose TissueAnimalsBone DensityBone Diseases, MetabolicBone Marrow CellsHumans

Identifiers

PMID23393168
PMCPMC3590487
OpenAlexW2053712883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.